Most Awaited Q3 Sale is back. Upto 30% discount on every report.

Optical Coherence Tomography Market Size, Share, Industry, Forecast and outlook (2023-2030)

Published: 2023 August 31
SKU : MD16
180 pages
Report Summary
Table of Contents
List of Tables & Figures

Optical Coherence Tomography Market is segmented by Product Type (Handheld, Tabletop, Doppler, Catheter-based and Others), By Volume Scan (Annular, Raster, Radial, and Others), By Technology (Frequency Domain, Spatially Encoded Frequency Domain, Time Domain, and Others), By Application (Ophthalmology, Cardiology, Dermatology, Oncology and Others), By End-Users (Hospitals, Specialty Clinics, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2023-2030


Report Overview

Global Optical Coherence Tomography Market reached US$ 1.5 billion in 2022 and is expected to reach US$ 2.8 billion by 2030, growing with a CAGR of 8.7% during the forecast period 2023-2030.

Optical coherence tomography utilizes light for the cross-sectional imaging of the tissue arrangement on the micron scale, in situ, and in real time. It is a non-invasive imaging procedure, which is employed to conduct optical biopsies. It is employed in sites where conventional imaging approaches cannot be utilized. OCT is established on fiber optics and can be combined with the tools, like catheters, laparoscopes, endoscopes, and surgical probes, which facilitate imaging of the body.

A significant benefit of OCT over the ophthalmoscopic investigation in vitreoretinal disorder management is the capacity to confine three-dimensional associations between the vitreous, retina, and extraretinal membranes. The applications of OCT enclose the diagnosis of various eye disorders such as the macular hole, macular edema, macular pucker, glaucoma, age-related macular degeneration, central serous retinopathy, vitreous traction, diabetic retinopathy, etc. Presently, OCT is also utilized for the detection and diagnosis of other additional disorders such as cardiovascular diseases, non-melanoma skin cancer, prostate cancer, and age-related macular disease, among other.

The Optical coherence tomography is primarily boosted by the growing cases of opthalmic disorders, increasing market developments including mergers, acquisitions, and product launches among others. Further, the increasing efforts to spread awareness about opthamic disorders and growing cases of other chronic disorders including cardiovascular disorders, non-melanoma skin cancer, prostate cancer, and age-related macular disease, among others are also contributing to the global market growth in the forecast period.

Market Scope





Size Available for Years


Forecast Period


Data Availability

Value (US$) 

Segments Covered

Product Type, Volume Scan, Technology, Application, End-User

Regions Covered

North America, Europe, Asia-Pacific, South America, and Middle East & Africa

Fastest Growing Region


Largest Region

North America

Report Insights Covered

Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and Acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, Porter’s Analysis, Pricing Analysis, Regulatory Analysis, Supply-Chain Analysis and Other key Insights.


For more details on this report Request for Sample


Market Dynamics

Increasing Cases of Ophthalmic Disorder

Early detection and monitoring are essential to the diagnosis and management of glaucoma, an advanced optic neuropathy that induces irreversible blindness. Optical coherence tomography (OCT) has evolved into a typically employed imaging modality that assists in the detection and monitoring of structural glaucomatous deterioration. Thus, the high prevalence of diabetic retinopathy is expected to boost the global market growth during the forecast period. For instance, the diabetic retinopathy concerns injury to the eye’s retina owing to high blood sugar levels in the blood. It is an expected intricacy of diabetes, impacting millions of individuals with both type 1 and type 2 diabetes.

Further, the growing cases of other ophthalmic disorders are also expected to be contributing to the global market growth in the forecast period. For instance, according to the WHO 2023, globally, at least 2.2 billion individuals are with near or distant vision impairment, and out of these around 1 billion vision impairment could have been averted or is yet to be handled. The top reasons for vision impairment and blindness at a multinational level are refractive disorders and cataracts.

Among these 1 billion individuals, the primary disorders inducing distance eyesight impairment or blindness include cataracts affecting over 94 million individuals, refractive error impacting around 88.4 million people, age-related macular degeneration with over 8 million cases, glaucoma affecting about 7.7 million individuals, and the diabetic retinopathy with over 3.9 million cases. The major disorder inducing near eyesight impairment is presbyopia an age-associated disease with around 826 million individuals impacted.

Increasing Number of Market Developments

The increasing number of market developments including, mergers, collaboration, product launches, and takeovers, among others are boosting the global market growth in the forecast period. For instance, in November 2021,  Heidelberg Engineering revealed the Spectralis platform, which is provided with shift technology, improves productivity in OCTA and OCT, and also allows clinicians to switch OCT scan pace for a better-personalized assessment. The Spectralis platform delivers three scan rates, 20 kHz, 85 kHz, and 125 kHz.

Moreover, in July 2021, Canon Singapore introduced the Xephilio OCT-S1, an innovative wide-field swept-source optical coherence topography competent for capturing high-resolution images of up to 23×20 mm in a single scan. Also, in June 2021, Perimeter Medical Imaging AI, Inc. conducted the technology transfer of its manufacturing methodology for the production of its optical coherence tomography (OCT) imaging systems with Minnetronix Medical. Again, in October 2021, NIDEK introduced the Retina Scan Duo 2, an integration of a fundus camera and OCT. The Retina Scan Duo 2 is provided with characteristics that enhance screening, and clinical effectiveness, and additionally helps enhance clinical workflow.

High Optical Coherence Tomography Device Cost

The high cost of the optical coherence tomography devices is expected to hamper the global market growth as due to the high cost the practitioners with low capital investments can not afford to buy a new device and instead of which use refurbished ones, slowing the market growth. For instance, the PRIMUS 200 from Zeiss costs around US$ 19,999.00, the OCT cirrus 5000 from the same manufacturer costs about US$ 15,999.00, Topcon OCT 2000 and DRI OCT Triton both from Topocon costs about US$ 7,500.00 and US$ 12,900.00 respectively. 

The optical coherence tomography device cost varies based upon the features included the device with advanced features costs more compared to the one with basic features for example iScan OCT from Optovue costs around US$ 12,000.00 as it includes some advanced features which deliver simplified operations while the ivue OCT from the same manufacturer costs about US$ 9,999.00 having basic features.

Opthalmologists Workforce Shortage

The shortage of ophthalmologists workforce is expected to slow the global market growth during the forecast period. For instnace, according to the Royal College of Ophthalmologists, the extensive bulk of NHS ophthalmology services are encountering substantial capability stresses, with more than three-quarters (76%) of teams not including an adequate number of consultants to satisfy existing patient needs and more than a half (52%) discovering it is additionally challenging to recruit consultants over the previous 12 months.

Moreover, in January 2023, there were more than 632,000 patients on ophthalmology waiting checklists in England sole and 24,000 of which were waiting for more than a year. Around 74% of eye units are additionally concerned regarding the effect of outpatient backlogs on patient upkeep than they were 12 months back and 63% assess it might take over a year to alleviate their outpatient backlogs. Further, the workforce's lack of NHS eyecare assistance is expected to decline, with a quarter (26%) of ophthalmologists in the UK thinking to exit the workforce over the next five years.

Segment Analysis

The global optical coherence tomography market is segmented based on product type, volume scan, technology, application, end-user and region.

Cancer Application of OCT Expected to Dominate Market

The oncology application of the OCT is expected to dominate the global market owing to the increasing number of positive outcomes from investigations intended to assess the efficacy of OCT in cancer diagnosis. For instance, in an investigation, investigators corresponded the diagnostic precision of clinical and dermoscopic examination (CDE) with that of CDE integrated with OCT for detecting recurrent or residual BCC post topical therapy of superficial BCC. When utilized in integration with the clinical and dermoscopic study, optical coherence tomography remarkably enhanced the capability to notice recurrent or residual basal cell carcinomas post-topical treatment.

Moreover, in July 2023, a transnational group of investigators improved the procedure of optical coherence tomography (OCT) which carries importance for ophthalmology, dermatology, cardiology, and the early diagnosis of cancer. The work was instructed by the University of Adelaide, Technical University of Denmark (DTU), Aerospace Corp., and the University of St. Andrews. 

Also, in August 2022, the Lancet Oncology presented ground-breaking conclusions on Michelson Diagnostics, the UK-based medical device corporation that uses multi-beam Optical Coherence Tomography ('OCT') technology, which can convert patient therapy and maintenance of basal cell carcinomas (BCC). It was inferred that OCT-guided diagnosis, when corresponding to a classic punch biopsy could decrease the number of consultations and invasive approaches by a huge 66%.

Geographical Share

Increasing Number of Ophthalmic Disorders Cases in North America

The increasing prevalence of ophthalmic disorders in North America is expected to boost regional market growth in the forecast period. For instance, in the United States independently, almost 12 million individuals aged 40 and overhead encountered eyesight impairment, with almost a million suffering from blindness. The CDC notifies that 17.2% of Americans above 40 years of age have a cataract in at least one eye accounting for around 20.5 million individuals. By 2028, above 30 million individuals are expected to suffer from cataracts. The CDC assesses that 4.1 million Americans are impacted with diabetic retinopathy, and almost 900,000 Americans are threatened with vision-damaging retinopathy. 

With the growth in life expectancy, diabetes, and other chronic conditions, the cases of eye disorders are anticipated to increase twofold by the year 2050. Age-related macular degeneration (AMD) is the highly expected reason for irreversible eyesight loss in older adults (70 years and older), with an assessed 9 million Americans suffering from intermediate or progressive AMD. Moreover, in 2021, an assessed 9.6 million individuals in the United States, 26% of those having diabetes encountered eye disease, and almost 2 million suffered the most extreme form, "vision-threatening diabetic retinopathy" (VTDR).

Further, the increasing government initiatives to fight against the growing prevalence of eye disorders in the region also contribute to the regional market growth in the forecast period. For instance, in December 2022, congress declared its long-awaited Fiscal Year (FY) 2023 expenditure ruling, which retains a sum of $6.5 million for vision and eye health agendas at the Centers for Disease Control and Prevention (CDC). 

In certain, the omnibus spending ruling would sponsor the Vision Health Initiative (VHI) at $2.5 million in FY2023, a $1 million growth over FY2022. The addition would support measures to revise national preponderance assessments on vision impairment and eye disorder. The CDC’s Glaucoma project, which supports community-based agendas that unite high-risk patients to eye care, would persist to be sponsored at $4 million.

COVID-19 Impact Analysis

Presently, ophthalmic practice widely relies on optic coherence tomography (OCT) and optical coherence tomography angiography (OCT-A), which are objective, reliable, and repeatable structural difficulties for both earlier diagnosis and detection of the advancement of various ocular conditions. The missed clinic visits advanced dramatically during the COVID-19 pandemic, particularly among elderly and nonwhite patients. These findings reflect differences in eye care delivery during the pandemic and they indicate possibilities to target barriers to care, even during non-pandemic eras.

However, individuals responded in diverse patterns to COVID-19 conditions. While some individuals produced mild to extreme respiratory issues, others encounter no manifestations at all. Pink eye remained the most typical manifestation of COVID in the eyesight of children and adults. Thus, COVID-19 is estimated to hold intermediate impact over the global market growth in the forecast period.

Russia-Ukraine Impact

The Russia Ukraine conflict is expected to have a very little impact over the global market, since the foremost weeks of the attack, Eyes on Ukraine, a humanitarian effort directed by ophthalmologists from across the nation, has been raising funds and shipping medication and surgical supplies to Ukraine ophthalmologists, with multiple reports from hospitals and war crews close to the front that the cargoes are making a general distinction.

Obtaining reserves into the nation, however, has demanded invention and the forging of a trusted network of people, including European ophthalmologists and Polish and Ukrainian mountain defenses, to assure safe transportation of the goods via Poland to Western Ukraine. There, they are distributed by the Ukrainian Vitreoretinal Society to where they are needed considerable. The initiative is believed to be the most active and organized humanitarian help initiatives sustaining eye trauma in the Russian invasion of Ukraine.

By Product Type

  • Handheld
  • Tabletop
  • Doppler
  • Catheter Based
  • Others

By Volume Scan

  • Annular
  • Raster
  • Radial
  • Others

By Technology

  • Frequency Domain
  • Spatially Encoded Frequency Domain
  • Time Domain
  • Others

By Application

  • Ophthalmology
  • Cardiology
  • Dermatology
  • Oncology
  • Others

By End-User

  • Hospitals
  • Specialty Clinics
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Rest of Europe
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • Rest of Asia-Pacific
  • Middle East and Africa

Key Developments

  • In January 2023, Thorlabs acquired JML Optical, a US-based precision optics firm. The acquisition of JML Optical broadens Thorlabs’ optical elements offerings. Cashing on JML’s optic abilities and manufacturing & innovation presence in Rochester, New York allows Thorlabs to provide revolutionary innovations for the photonics market.
  • In February 2023, NIDEK launched AL-Scan M Optical Biometer and MV-1 Myopia Viewer software. The AL-Scan is crucial for assessing young children and provides smooth patient flow. The biometer measures axial length, which is believed to be an perfect parameter for evaluating myopia.
  • In October 2022, the European Association of Neurosurgical Societies and ZEISS Medical Technology formed a strategic cooperation (EANS). The business expects that through this association, it expects to be capable of assisting in the training and additional education of neurosurgical professionals, facilitating the exchange of knowledge between users and medical equipment manufacturers, and enhancing scientific progress in the domain of neurosurgery.

Market Players

The major global players in the market include Thorlabs, Inc., ZEISS, Topcon Corporation, Leica Microsystems, NIDEK CO., LTD., Heidelberg Engineering Inc., Alcon Inc., Canon Medical Systems, USA., Visionix Ltd. , Abbott, Icare USA, Inc., and OPTOPOL Technology Sp among others.

Why Purchase the Report?

  • To visualize the global optical coherence tomography market segmentation based on product type, volume scan, technology, application, end-user and region as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development. 
  • Excel data sheet with numerous data points of optical coherence tomography market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as excel consisting of key product of all the major players.

The global optical coherence tomography market report would provide approximately 61 tables, 58 figures and 186 Pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies
Buy this report
Single User
Multiple User
Enterprise User
Proceed to Buy
Request new version
What is the Projected CAGR value of the Optical Coherence Tomography Market ?
Global Optical Coherence Tomography Market is expected to grow at a CAGR of 8.7% during the forecasting period 2023 - 2030.
Who are the major competitors in Optical Coherence Tomography Market ?
Major players are ZEISS, Topcon Corporation, Leica Microsystems, NIDEK CO., LTD., Heidelberg Engineering Inc., Alcon Inc, Canon Medical Systems, USA., Visionix Ltd, Abbott, Icare USA, Inc. and OPTOPOL Technology Sp.